ScoreWhy is Corline Biomedical AB ?
1
The company has declared Negative results for the last 7 consecutive quarters
- NET PROFIT(HY) At SEK -7.24 MM has Grown at -219.22%
- OPERATING CASH FLOW(Y) Lowest at SEK -16.71 MM
- ROCE(HY) Lowest at -28.03%
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 151.41%, its profits have fallen by -108.8%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Corline Biomedical AB for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Corline Biomedical AB
152.07%
0.93
68.20%
OMX Stockholm 30
8.01%
0.51
18.11%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
42.81%
EBIT Growth (5y)
-12.23%
EBIT to Interest (avg)
-5.38
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
0.21
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.00%
ROE (avg)
0.88%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.14
EV to EBIT
-35.97
EV to EBITDA
-36.24
EV to Capital Employed
6.73
EV to Sales
60.62
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-18.71%
ROE (Latest)
-16.74%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
NET PROFIT(HY)
Higher at SEK -7.24 MM
-23What is not working for the Company
NET PROFIT(HY)
At SEK -7.24 MM has Grown at -219.22%
OPERATING CASH FLOW(Y)
Lowest at SEK -16.71 MM
ROCE(HY)
Lowest at -28.03%
RAW MATERIAL COST(Y)
Grown by 220.37% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.42%
NET SALES(Q)
At SEK 2.06 MM has Fallen at -15.91%
Here's what is working for Corline Biomedical AB
Net Profit
Higher at SEK -7.24 MM
than preceding 12 month period ended Mar 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (SEK MM)
Here's what is not working for Corline Biomedical AB
Net Profit
At SEK -7.24 MM has Grown at -219.22%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (SEK MM)
Operating Cash Flow
Lowest at SEK -16.71 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (SEK MM)
Net Sales
At SEK 2.06 MM has Fallen at -15.91%
over average net sales of the previous four periods of SEK 2.44 MMMOJO Watch
Near term sales trend is negative
Net Sales (SEK MM)
Debtors Turnover Ratio
Lowest at 2.42%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 220.37% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
